146 related articles for article (PubMed ID: 26963597)
1. Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives.
Chauhan A; Paladhi S; Debnath M; Dash J
Org Biomol Chem; 2016 Jun; 14(24):5761-7. PubMed ID: 26963597
[TBL] [Abstract][Full Text] [Related]
2. A small molecule peptidomimetic that binds to c-KIT1 G-quadruplex and exhibits antiproliferative properties in cancer cells.
Chauhan A; Paladhi S; Debnath M; Mandal S; Das RN; Bhowmik S; Dash J
Bioorg Med Chem; 2014 Aug; 22(16):4422-9. PubMed ID: 24961873
[TBL] [Abstract][Full Text] [Related]
3. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
[TBL] [Abstract][Full Text] [Related]
4. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
[TBL] [Abstract][Full Text] [Related]
5. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
[TBL] [Abstract][Full Text] [Related]
6. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.
Peng D; Tan JH; Chen SB; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2010 Dec; 18(23):8235-42. PubMed ID: 21036049
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands.
Jiang Y; Chen AC; Kuang GT; Wang SK; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2016 Oct; 122():264-279. PubMed ID: 27372288
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic and biological studies of phenanthroline compounds: selective recognition of gene-promoter G-quadruplex DNAs preferred over duplex DNA.
Wang L; Wei C
Chem Biodivers; 2013 Jun; 10(6):1154-64. PubMed ID: 23776031
[TBL] [Abstract][Full Text] [Related]
9. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
11. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel 11-Triazole Substituted Benzofuro[3,2-b]quinolone Derivatives as c-myc G-Quadruplex Specific Stabilizers via Click Chemistry.
Zeng DY; Kuang GT; Wang SK; Peng W; Lin SL; Zhang Q; Su XX; Hu MH; Wang H; Tan JH; Huang ZS; Gu LQ; Ou TM
J Med Chem; 2017 Jul; 60(13):5407-5423. PubMed ID: 28514170
[TBL] [Abstract][Full Text] [Related]
13. A Nucleus-Imaging Probe That Selectively Stabilizes a Minor Conformation of c-MYC G-quadruplex and Down-regulates c-MYC Transcription in Human Cancer Cells.
Panda D; Debnath M; Mandal S; Bessi I; Schwalbe H; Dash J
Sci Rep; 2015 Aug; 5():13183. PubMed ID: 26286633
[TBL] [Abstract][Full Text] [Related]
14. Photoisomerizable arylstilbazolium ligands recognize parallel and antiparallel structures of G-quadruplexes.
Czerwinska I; Juskowiak B
Int J Biol Macromol; 2012 Nov; 51(4):576-82. PubMed ID: 22750579
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and binding studies of novel diethynyl-pyridine amides with genomic promoter DNA G-quadruplexes.
Dash J; Waller ZA; Pantoş GD; Balasubramanian S
Chemistry; 2011 Apr; 17(16):4571-81. PubMed ID: 21387430
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression.
Agarwal T; Roy S; Chakraborty TK; Maiti S
Biochemistry; 2010 Sep; 49(38):8388-97. PubMed ID: 20712380
[TBL] [Abstract][Full Text] [Related]
18. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
[TBL] [Abstract][Full Text] [Related]
19. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription.
Agarwal T; Roy S; Chakraborty TK; Maiti S
Bioorg Med Chem Lett; 2010 Aug; 20(15):4346-9. PubMed ID: 20615700
[TBL] [Abstract][Full Text] [Related]
20. Identification of a selective G-quadruplex DNA binder using a multistep virtual screening approach.
Hou JQ; Chen SB; Zan LP; Ou TM; Tan JH; Luyt LG; Huang ZS
Chem Commun (Camb); 2015 Jan; 51(1):198-201. PubMed ID: 25388435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]